Jim Kastenmayer
2022
In 2022, Jim Kastenmayer earned a total compensation of $865.8K as General Counsel, Corporate Secretary and Former Interim Chief Executive Officer at Aeglea BioTherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $155,694 |
|---|---|
| Option Awards | $253,948 |
| Salary | $443,943 |
| Other | $12,200 |
| Total | $865,785 |
Kastenmayer received $443.9K in salary, accounting for 51% of the total pay in 2022.
Kastenmayer also received $155.7K in non-equity incentive plan, $253.9K in option awards and $12.2K in other compensation.
Rankings
In 2022, Jim Kastenmayer's compensation ranked 3,287th out of 5,542 executives tracked by ExecPay. In other words, Kastenmayer earned more than 40.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,287 out of 5,542 | 41st |
Division Manufacturing | 1,846 out of 3,000 | 39th |
Major group Chemicals And Allied Products | 872 out of 1,350 | 35th |
Industry group Drugs | 815 out of 1,253 | 35th |
Industry Pharmaceutical Preparations | 592 out of 907 | 35th |
Source: SEC filing on October 26, 2023.
Kastenmayer's colleagues
We found four more compensation records of executives who worked with Jim Kastenmayer at Aeglea BioTherapeutics in 2022.